Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity
Authors:
- 1 October 1997
- journal article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 27 (10) , 1160-1166
Abstract
Summary: Background Cetirizine is an antihistamine, largely used in the treatment of allergic rhinoconjunctivitis, which also exerts anti‐allergic activity.Objectives To evaluate cetirizine as treatment for children with rhinitis due to pollen allergy, and to evaluate its anti‐allergic activity in such a clinical condition.Methods The study was designed as parallel groups, double‐blind, placebo‐controlled, randomized. Twenty allergic children were enroled and subdivided in two groups, receiving a 4 week treatment during the pollen season. The following parameters were monitored: clinical symptoms evaluated by the allergist before and after treatment and by the patients through a daily diary card, inflammatory cells count, expression of ICAM‐1 on nasal epithelial cells, inflammatory mediator levels in nasal Iavage and peripheral blood before and after treatment, and pollen counts.Results This study shows that cetirizine treatment is able to reduce: clinical symptoms (P < 0.01), inflammatory cell infiltrate (P < 0.03), ICAM‐1 expression on epithelial cells (P < 0.05), and soluble ICAM‐1 (P < 0.05) and ECP (P < 0.05) in nasal lavage.Conclusion Cetirizine is able to clinically improve nasal symptoms due to pollen allergy and to reduce allergic inflammation, which is related to allergen exposure.Keywords
This publication has 18 references indexed in Scilit:
- Cetirizine Reduces ICAM-I on Epithelial Cells during Nasal Minimal Persistent Inflammation in Asymptomatic Children with Mite-Allergic AsthmaInternational Archives of Allergy and Immunology, 1996
- Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challengeJournal of Allergy and Clinical Immunology, 1995
- Allergen-Specific Challenge Induces Intercellular Adhesion Molecule 1 (ICAM-1 or CD54) on Nasal Epithelial Cells in Allergic Subjects. Relationships with Early and Late Inflammatory PhenomenaAmerican Journal of Respiratory and Critical Care Medicine, 1994
- The anti-inflammatory effects of cetirizineClinical & Experimental Allergy, 1994
- CetirizineDrugs, 1993
- Allergic subjects express intercellular adhesion molecule — 1 (ICAMA or CD54) on epithelial cells of conjunctiva after allergen challengeJournal of Allergy and Clinical Immunology, 1993
- A possible role for adhesion molecules in asthmaJournal of Allergy and Clinical Immunology, 1992
- The migration of eosinophils into the sputum of asthmatics: the role of adhesion moleculesClinical & Experimental Allergy, 1992
- Mucosal Inflammation in AsthmaAmerican Review of Respiratory Disease, 1990
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984